KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Capital Expenditures (2020 - 2025)

Clover Health Investments' Capital Expenditures history spans 6 years, with the latest figure at $597000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 89.52% year-over-year to $597000.0; the TTM value through Dec 2025 reached $2.0 million, up 31.3%, while the annual FY2025 figure was $2.0 million, 31.3% up from the prior year.
  • Capital Expenditures reached $597000.0 in Q4 2025 per CLOV's latest filing, down from $692000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $3.9 million in Q4 2022 to a low of -$264000.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $468650.0, with a median of $255000.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: soared 1528.99% in 2022, then plummeted 106.81% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $238000.0 in 2021, then skyrocketed by 1528.99% to $3.9 million in 2022, then tumbled by 106.81% to -$264000.0 in 2023, then soared by 219.32% to $315000.0 in 2024, then soared by 89.52% to $597000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Capital Expenditures are $597000.0 (Q4 2025), $692000.0 (Q3 2025), and $569000.0 (Q2 2025).